Evariste Technologies

Evariste aims to enhance the productivity of drug discovery through automated molecular design, integrating expertise in medicinal chemistry and drug discovery to accelerate the identification of new small-molecule therapies. Evariste has several ongoing early-stage projects focused on oncology and antimicrobial drugs. By utilizing multi-objective optimization scoring functions, Evariste can identify candidate molecules faster than traditional design cycles. Evariste Technologies leverages mathematics to enhance drug discovery, and through machine learning, Bayesian statistics, and game theory, we have developed a robust optimization cycle to expedite drug discovery.